|Articles|January 10, 2017
Profil Institute Becomes ProSciento, Inc.
Profil Institute for Clinical Research, Inc. has announced the launch of its new corporate name, ProSciento Inc.
Advertisement
Profil Institute for Clinical Research, Inc. has announced the launch of its new corporate name, ProSciento Inc. Under a broader rebranding campaign, the name change represents the company’s focus on metabolism clinical R&D for diabetes, obesity and NAFLD/NASH.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Evinova, Bristol Myers Squibb Partner to Apply AI to Global Clinical Development
2
SCOPE Summit 2026: How Sponsors Are Prioritizing AI Adoption Across Clinical Trials
3
Interdependence-Aware Attribution in Real-World Evidence: A Case Study on Semaglutide Weight Loss Outcomes
4
SCOPE Summit 2026: How Payment Practices and Operational Burden Are Changing Site Behavior
5